Suzhou Highfine Biotech Co Ltd Class A Shares 301393

Morningstar Rating

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

301393 is trading at a 752% premium.
Price
¥37.42
Fair Value
¥43.38
Uncertainty
Very High
1-Star Price
¥41.29
5-Star Price
¥85.92
Economic Moat
Ljwvd
Capital Allocation

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
43.14
Price/Sales
9.87
Dividend Yield (Trailing)
0.67%
Dividend Yield (Forward)
0.67%
Total Yield
0.67%

Company Profile

Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
349

Comparables

Valuation

Metric
301393
688076
301520
Price/Earnings (Normalized)
43.1435.1820.97
Price/Book Value
1.835.041.76
Price/Sales
9.878.516.72
Price/Cash Flow
30.3419.1521.80
Price/Earnings
301393
688076
301520

Financial Strength

Metric
301393
688076
301520
Quick Ratio
25.120.9819.29
Current Ratio
26.781.3720.34
Interest Coverage
1,547.4017.43
Quick Ratio
301393
688076
301520

Profitability

Metric
301393
688076
301520
Return on Assets (Normalized)
5.58%10.45%9.63%
Return on Equity (Normalized)
5.86%16.43%10.33%
Return on Invested Capital (Normalized)
3.16%12.34%9.79%
Return on Assets
301393
688076
301520

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
TjkqllhrKrhm$88.3 Bil
Merck KGaA ADR
MKKGY
YydtwcfkxVcnjqq$77.4 Bil
Haleon PLC ADR
HLN
LwtqcktSlgh$47.3 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
GvbzbvnlMjp$19.0 Bil
Viatris Inc
VTRS
HmtyrntclKvcc$13.9 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
NyxgpdllPlnyn$13.4 Bil
Catalent Inc
CTLT
SfygytpvrDwcsddb$10.9 Bil
Prestige Consumer Healthcare Inc
PBH
MknxrzqvrSxvytz$3.5 Bil
Perrigo Co PLC
PRGO
MkssdrvrFbwl$3.5 Bil
Green Thumb Industries Inc
GTBIF
RrbdkfyhqTrxj$2.5 Bil

Sponsor Center